» Scientific divisions on covid-19: time for open debate
25/11/20 14:16 from Latest headlines from BMJ
McKee and Stuckler, two notable policy analysts, present their personal view that scientific splits on covid-19 are not what they seem.1 Rather than present data to support their opinions, however,...
» Covid-19: Government was too slow to respond to ventilator shortages, say MPs
25/11/20 12:16 from Latest headlines from BMJ
The NHS managed to provide care for all patients affected by covid-19 who needed ventilators earlier this year despite the government being underprepared and slow in responding to hospitals’ needs,...
» Need for ethical framework to guide mass testing for asymptomatic covid-19
24/11/20 12:51 from Latest headlines from BMJ
A mass covid-19 screening programme has been rolled out in Liverpool,1 with further plans announced for mass testing of asymptomatic university students across England before they return home for the...
» Covid-19 vaccine: we are sleepwalking into a massive prospective cohort study
24/11/20 12:40 from Latest headlines from BMJ
I was delighted to finally read some sensible journalistic challenges to the matters surrounding a covid-19 vaccine.1 I waited for further probing articles in the medical and national press, hoping...
» Covid-19: England will return to regional restrictions amid rapid testing push
24/11/20 12:31 from Latest headlines from BMJ
England will move to a revised system of regional, tiered restrictions when the current national lockdown ends on 2 December, the prime minister has announced.In a statement to the House of Commons...
» Covid-19: What do we know about the late stage vaccine candidates?
24/11/20 10:46 from Latest headlines from BMJ
University of Oxford and AstraZeneca vaccineThe ChAdOx1 nCoV-19 has been tested across the world, with trials starting in the UK and branching out to Brazil, South Africa, and the US. Phase II...
» Remdesivir: a pendulum in a pandemic
24/11/20 10:26 from Latest headlines from BMJ
Covid-19 has claimed over a million lives globally and devastated healthcare systems, economies, and societal welfare. Determining effective, safe, and scalable prevention and treatment measures is...
» Covid -19, misinformation, and antimicrobial resistance
24/11/20 10:25 from Latest headlines from BMJ
Well before covid-19, the world already faced an emergent threat of antimicrobial resistance, and many have sounded the alarm over further escalation during the pandemic.1 A study from the US, for...
» Matt Morgan: The two pandemics—covid and lies
24/11/20 10:13 from Latest headlines from BMJ
It’s been a long weekend. The growing number of my colleagues self-isolating has led to increasing gaps in our rota. Combined with the unwelcome return of covid-19 to intensive care units throughout...
» A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
24/11/20 10:01 from Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
New England Journal of Medicine, Ahead of Print.
» Mining a GWAS of Severe Covid-19
24/11/20 10:01 from Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
New England Journal of Medicine, Ahead of Print.
» A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
24/11/20 10:00 from Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
New England Journal of Medicine, Ahead of Print.
» Risk Factors for SARS-CoV-2 in a Statewide Correctional System
24/11/20 10:00 from Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
New England Journal of Medicine, Ahead of Print.
» Hand Hygiene Gaps Identified
24/11/20 00:00 from JAMA Current Issue
Hand washing or using an alcohol-based hand sanitizer after touching shopping carts, gas pumps, automated teller machines, and other frequently touched surfaces is a key strategy the CDC recommends to curb the spread of coronavirus disea...
» Study Aims to Identify Drugs That Could Be Repurposed for COVID-19
24/11/20 00:00 from JAMA Current Issue
The National Institute of Allergy and Infectious Diseases (NIAID) recently launched a study to determine whether drugs that are already approved or in the late stage of clinical development might merit testing in larger clinical trials a...
» Reflections of a COVID-19 Long Hauler
24/11/20 00:00 from JAMA Current Issue
In this narrative medicine essay, an emergency medical physician describes the lasting physical symptoms of a mild case of COVID-19, the effects of the illness on his family and professional community, and the lessons he’s learned about ...
» SARS-CoV-2 Testing Hesitancy Could Hamper Mitigation Efforts
24/11/20 00:00 from JAMA Current Issue
This Medical News feature examines the problem of people refusing to be tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
» Principles Underlying ACIP Recommendations for Phased Implementation for COVID-19 Vaccination
24/11/20 00:00 from JAMA Current Issue
This Viewpoint summarizes the principles guiding coronavirus disease 2019 (COVID-19) vaccine recommendations made by the Advisory Committee on Immunization Practices (ACIP), a nongovernment advisory standing committee that counsels the C...
» Herd Immunity and Implications for SARS-CoV-2 Control
24/11/20 00:00 from JAMA Current Issue
This JAMA Insights Clinical Update discusses herd immunity in the context of the COVID-19 pandemic and explains the herd immunity threshold as a function of transmissibility (R0), the role of an effective vaccine and vaccination program ...
» Answering Key Questions About Coronavirus Vaccines
24/11/20 00:00 from JAMA Current Issue
This Viewpoint offers provisional answers to common questions the public will have about approved COVID-19 vaccines, including what they can expect regarding its effectiveness and safety, trustworthiness of the approval process, and whet...